Records 1 - 6 (of 6 Records)
|Query Trace: Schizophrenia and PRL[original query]|
| Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
Human psychopharmacology 2011 Jan 26 (1): 21-7.
Souza Renan P, Meltzer Herbert Y, Lieberman Jeffrey A, Voineskos Aristotle N, Remington Gary, Kennedy James
| Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis.
Psychoneuroendocrinology 2016 Jun 72 1-10.
Miura Itaru, Zhang Jian-Ping, Hagi Katsuhiko, Lencz Todd, Kane John M, Yabe Hirooki, Malhotra Anil K, Correll Christoph
| Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids.
General psychiatry 2020 7 33 (4): e100206.
He Sidi, Yu Wen Juan, Wang Xiaoliang, Zhang Lei, Zhao Nan, Li Guanjun, Shen Yi Feng, Li Huafa
| Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone.
BMC psychiatry 2021 Feb 21 (1): 70.
Lu Jinjun, Yang Ye, Lu Jian, Wang Zuqing, He Yiping, Yan Yeliang, Fu Kai, Jiang Wenjuan, Xu Yunqing, Wu Renrong, Liu Wenqing, Zhao Jingpi
| Schizophrenia plausible protective effect of microRNA-137 is potentially related to estrogen and prolactin in female patients.
Frontiers in psychiatry 2023 9 14 1187111.
Qian Peng, Zhun Dai, Jingwen Yin, Dong Lv, Xudong Luo, Susu Xiong, Zhijiang Yang, Guangmin Chen, Yaxue Wei, Ying Wang, Dandan Zhang, Lulu Wang, Debo Yu, Yusheng Zhao, Dele Lin, Zhiyu Liao, Yongxi Zhong, Zhixiong Lin, Juda L
| Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study.
Frontiers in psychiatry 2023 2 14 1124691.
Liu Xuebing, Sun Xianzhi, Li Lu, Zeng Kuan, Li Yi, Gao Yujun, Ma J